Incyte to Report Second Quarter Financial Results

WILMINGTON, Del.--(BUSINESS WIRE)--Jul. 8, 2026--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for8:00 a.m. ETonTuesday, July 28, 2026.

The schedule for the press release and conference call/webcast is as follows:

• Q2 2026 Press Release:July 28, 2026, at7:00 a.m. ET

• Q2 2026 Conference Call:July 28, 2026, at8:00 a.m. ET

• Domestic Dial-In Number: 877-407-3042

• International Dial-In Number: 201-389-0864

• Conference ID Number: 13759527

If you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for theU.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13759527.

A live webcast with slides can be accessed atInvestor.Incyte.comand will be available for replay for ninety days.

About IncyteIncyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.

To learn more, visitIncyte.comandInvestor.Incyte.com. Follow us on social media:LinkedIn,X, and Instagram.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260708563739/en/

Source: Incyte